Zyprexa Relprevv FDA Approval History
FDA Approved: Yes (First approved December 11, 2009)
Brand name: Zyprexa Relprevv
Generic name: olanzapine
Dosage form: for Extended Release Injectable Suspension
Company: Eli Lilly and Company
Treatment for: Schizophrenia
Zyprexa Relprevv (olanzapine) is a long-acting atypical antipsychotic for intramuscular injection indicated for the treatment of schizophrenia.
Development timeline for Zyprexa Relprevv
| Date | Article |
|---|---|
| Dec 14, 2009 | Approval FDA Approves Lilly's Zyprexa Relprevv for Treatment of Schizophrenia in Adults |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
